Risk Of Developing Liver Cancer After HCV Treatment

Thursday, February 9, 2017

Replay - Strategies to address reimbursement restrictions for Hep C treatment

Strategies to address reimbursement restrictions for Hep C treatment: Lessons from Australia

Click here to review; Strategies to address reimbursement restrictions for Hep C treatment: Lessons from Australia, a webinar presented by CATIE, CanHep C and The Kirby Institute, which took place on February 6, 2017.

http://www.catie.ca/en/webinars/strategies-address-reimbursement-restrictions-daa-therapy-lessons-australia

CATIE, CanHepC, CTAC and The Kirby Institute, will explore how Canada could move beyond its current restrictive and inconsistent approach to DAA access.  The webinar will showcase the Australian model, which allows all people access to hepatitis C treatment, including people who inject drugs and people in prison.  This webinar will examine what social and environmental factors led to this model and what policy-makers, service providers and community activists in Canada can learn from the Australian experience.

Learn from experts such as Alison Marshall and Greg Dore of Australia’s The Kirby Institute; and Helen Tyrell of Hepatitis Australia. Engage in discussion with Adam Cook of CTAC and Action Hepatitis Canada; Community Organizer Zoe Dodd.

Download Powerpoint/PDF File:australia-webinar-combined.pdf
Listen here....

Of Interest
Podcast - HCV Treatment Accessibility in the United States (Texas) discusses accessibility for patients w-Medicare/Medicaid.
Listen here....

No comments:

Post a Comment